Keytruda may be a miracle cancer drug By Steve|2024-10-11T16:13:34+10:00July 29th, 2018|Categories: All, Funding, Immunotherapy, Z-Legacy|Tags: Keytruda| Read More 0
Vyriad Expands Phase 1 Trial to Test Voyager-V1 By Steve|2024-10-11T16:13:35+10:00July 28th, 2018|Categories: All, Clinical Trials, Immunotherapy, Media, Z-Legacy|Tags: Bavencio, Colorectal Cancer, PD-L1, virotherapy, Voyager-V1| Read More 0
Rare Cancers Australia 33 Million Win By Steve|2024-10-11T16:13:35+10:00July 24th, 2018|Categories: All, Funding, Z-Legacy|Tags: Australia, Funding, Government, Rare Cancers| Read More 0
Cycling in the Chemo By Steve|2024-10-11T16:13:35+10:00July 18th, 2018|Categories: All, Chemotherapy, Z-Legacy|Tags: Australia, Chemotherapy, Exercise| Read More 0
Bile Duct Cancer – How it develops and how to prevent it By Steve|2024-10-11T16:13:35+10:00April 23rd, 2018|Categories: All, Prevention, Z-Legacy|Tags: bile Duct Cancer, How| Read More 0
Capecitabine Improves Survival of Patients with Rare Cancer by Almost a Quarter By Steve|2024-10-11T16:13:36+10:00April 23rd, 2018|Categories: All, Chemotherapy, Z-Legacy|Tags: capecitabine, Chemotherapy| Read More 0
CC with Andrew Clacher By Steve|2024-10-11T16:13:36+10:00February 12th, 2018|Categories: All, PATIENT, Z-Legacy|Tags: Australia| Read More 0
Elishka’s Story By Steve|2024-10-11T16:13:36+10:00February 10th, 2018|Categories: All, PATIENT, Z-Legacy|Tags: Australia| Read More 0
Immunotherapy achieves dramatic results By Steve|2024-10-11T16:13:36+10:00January 11th, 2018|Categories: All, Immunotherapy, Z-Legacy|Tags: immunotherapy, Keytruda| Read More 0
Can Bile Duct Cancer’s follow the Melanoma lead By Steve|2024-10-11T16:16:00+10:00January 11th, 2018|Categories: All, Immunotherapy, Z-Legacy|Tags: immunotherapy, Keytruda, Melanoma, PD-L1, Pembrolizumab| Read More 0